new_0222_0621|TLIS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0621|TLIS|1|Talis Biomedical Corp Total Current Assets (Quarterly) (USD)|Talis Biomedical Corp Cash and Short Term Investments (Quarterly) (USD)|Talis Biomedical Corp Inventories (Quarterly) (USD)|Talis Biomedical Corp Net PP&E (Quarterly) (USD)|Talis Biomedical Corp Goodwill and Intangibles (Quarterly) (USD)|Talis Biomedical Corp Total Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Current Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Long Term Liabilities (Quarterly) (USD)|Talis Biomedical Corp Total Deposits (Quarterly) (USD)|Talis Biomedical Corp Book Value (Quarterly) (USD)|Talis Biomedical Corp Retained Earnings (Quarterly) (USD)|Talis Biomedical Corp Treasury Stock (Quarterly) (USD)|Talis Biomedical Corp EV to Revenues|Talis Biomedical Corp EV to Earnings|Talis Biomedical Corp EV to Free Cash Flow|Talis Biomedical Corp EV to Assets (Quarterly)|Talis Biomedical Corp PS Ratio|Talis Biomedical Corp PE Ratio|Talis Biomedical Corp Price to Book Value|Talis Biomedical Corp PEG Ratio|Talis Biomedical Corp Debt to Equity Ratio|Talis Biomedical Corp Dividend Yield|Talis Biomedical Corp Shareholder Yield (TTM)|Talis Biomedical Corp Percent of Shares Outstanding Short|Talis Biomedical Corp Total Receivables (Quarterly) (USD)|Talis Biomedical Corp Total Payables (Quarterly) (USD)|Talis Biomedical Corp Total Capital Stock (Quarterly) (USD)|Talis Biomedical Corp Return on Invested Capital|Talis Biomedical Corp Quality Ratio Score|Talis Biomedical Corp Momentum Score|Talis Biomedical Corp Beta (1Y)|Talis Biomedical Corp Sustainable Growth Rate (TTM)|Talis Biomedical Corp Institutional Investor Ownership Percentage|Talis Biomedical Corp Average Diluted Shares Outstanding (Quarterly)|Talis Biomedical Corp Total Employees (Annual)|Talis Biomedical Corp EPS Diluted (Quarterly) (USD)|Talis Biomedical Corp Shares Outstanding|Talis Biomedical Corp Repurchase of Capital Stock (Quarterly) (USD)|Talis Biomedical Corp Ordinary Shares Number (Quarterly)|Talis Biomedical Corp Payout Ratio|Talis Biomedical Corp Quick Ratio (Quarterly)|Talis Biomedical Corp Normalized Diluted EPS (Quarterly) (USD)|Talis Biomedical Corp Stock Buybacks (Quarterly) (USD)|Talis Biomedical Corp Effective Tax Rate (TTM)|Talis Biomedical Corp Return on Equity|Talis Biomedical Corp Net Income (TTM) (USD)|Talis Biomedical Corp Revenue (TTM) (USD)|Talis Biomedical Corp Dividend Per Share (Quarterly) (USD)|Talis Biomedical Corp Revenue (Quarterly) (USD)|Talis Biomedical Corp Gross Profit (Quarterly) (USD)|Talis Biomedical Corp SG&A Expense (Quarterly) (USD)|Talis Biomedical Corp Pre-Tax Income (Quarterly) (USD)|Talis Biomedical Corp Net Income (Quarterly) (USD)|Talis Biomedical Corp Net Interest Income (Quarterly) (USD)|Talis Biomedical Corp Price (USD)|Talis Biomedical Corp Total Return Price (USD)|Talis Biomedical Corp Enterprise Value (USD)|Talis Biomedical Corp 30-Day Average Daily Volume|Talis Biomedical Corp 1 Year Price Returns (Daily)||
new_0222_0621|TLIS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0621|TLIS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0621|TLIS|5|121.833333333|121.833333333||121.833333333||121.833333333|121.833333333|121.833333333||121.833333333|121.833333333||||1.44565217391||||1.44262295082|||1.44565217391||15.24|121.833333333|121.833333333|121.833333333||||||30.4166666667|91.375|365|91.375|33.25||121.833333333|||91.375|91.4285714286|||91.4|||||91.375|91.375|91.375||1.44565217391|1.44565217391|1.44565217391|1.44534412955|1.39130434783||
new_0222_0621|TLIS|6|6|6||6||6|6|6||6|6||||276||||244|||276||25|6|6|6||||||12|8|1|8|12||6|||8|7|||5|||||8|8|8||276|276|276|247|23||
new_0222_0621|TLIS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0621|TLIS|201912|24.107|21.604||1.535||46.873|4.037|42.836||-21.14|-81.776||||||||||||||1.806|1.566||||||||4.3603||-1.7512|||19.6799|||-1.7512|||||||||1.764|-7.636|-7.636|0.044|||||||
new_0222_0621|TLIS|202003||||||||||||||||||||||||||||||||||4.3603||-1.6912||||||-1.6912|||||||||2.08|-7.374|-7.374||||||||
new_0222_0621|TLIS|202006||||||||||||||||||||||||||||||||||4.3603||-2.304||||||-2.304|||||||||2.66|-10.046|-10.046||||||||
new_0222_0621|TLIS|202009|106.004|55.406||9.157||181.194|13.717|167.477||-65.942|-128.71||||||||||||||0.334|3.958||||||||4.3603||-6.7688|||19.6799|||-6.7688||||-54.57|||||3.058|-29.514|-29.514||||||||
new_0222_0621|TLIS|202012|188.724|138.483||9.681||306.976|16.031|290.945||-108.571|-172.906||||-3.1924|||||||||3.5558|0.471|4.906|||||||4.3816|19.6799|136|-2.2457|25.6362||19.6799|||-2.2457||||-91.13|||||5.305|-44.196|-44.196||17.26|17.26|303.9978||||
new_0222_0621|TLIS|202103|391.322|348.012||10.112||46.849|46.849|||356.33|-233.398||||0.1647||||0.9245|||||9.1811||10.826|0.005|||||||13.1107||-4.61|25.6376||25.6376|||-4.61|-233.348|||-144.248|||||7.327|-60.492|-60.492||12.85|12.85|-18.5658|405883||12|9.74
new_0222_0621|TLIS|202106|353.865|313.458||23.925||85.806|72.629|13.177||293.729|-297.87||||0.2239||||0.9647|||||7.0434|0.117|11.695|0.005||||||97.777|25.6482||-2.51|25.6904||25.6904|||-2.51|0.802|||-198.674|||||9.983|-64.472|-64.472||11.03|11.03|-30.0899|273422.3||10.3|8.06
new_0222_0621|TLIS|202109|277.557|273.603||23.791||44.304|31.342|12.962||258.789|-336.288||||0.6487||||0.627|||||5.3478|0.219|5.388|0.005||||||71.5594|25.7871||-1.49|25.963||25.963|||-1.49||||-207.578|||||12.792|-38.418|-38.418||6.25|6.25|-111.3313|237996.3667||5.35|4.68
new_0222_0621|TLIS|202112|236.115|232.545||23.435||31.851|19.106|12.745||233.974|-364.942||||0.7268||||0.4526|||||2.909|0.183|5.122|0.006||||||92.3231|32.3382|262|-1.085|26.408||26.408|||-1.085||||-192.036|||||12.316|-28.654|-28.654||4.01|4.01|-126.6459|217257.1333|-87.8911|2.95|2.09
new_0222_0621|TLIS|202203|||||||||||||||1.0964||||0.1774||||||||||||||||||26.7738||||||||||||||||||1.55|1.55|-191.0426|156292.4|-90.6851||